Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

344 public trials 109 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

NCT07221253

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
View all 174 locations
View Trial Details
Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT05482893

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

NCT07265674

Conditions
Adenocarcinoma, Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC), +12 more
Locations
  • City of Hope (Site 107) Duarte, California, United States
  • University of California at Irvine (Site 101) Orange, California, United States
  • UCLA Medical Center (Site 117) Santa Monica, California, United States
  • Moffitt Cancer Center Magnolia Campus (Site 123) Tampa, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NCT07458347

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +44 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions